CompanyGraph
What stands out
- Dividend several times the last twelve months' earnings
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- FinancialsAltman Z-Score 3.65: safe zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
What stands out
- Dividend several times the last twelve months' earnings
Dividends view
Yield
1.89%Below 5Y avg (5.96%)
Annual Rate
CNY 0.35Paid annual
Payout Ratio
357.9%High
Payback Period
58.0 yr
Last Ex-Dividend
May 27, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
7.78BCNY1.16B · vs all stocks (USD)
Trailing P/E
181.50xvs Medical Instruments & Supplies peers
Revenue (TTM)
2.61BCNY390.07M · vs all stocks (USD)
Profit Margin
1.55%vs Medical Instruments & Supplies peers
Beta
0.3860xvs all stocks
52-Week Change
36.40%vs all stocks
Market Capitalization
7.78BCNY1.16B · vs all stocks (USD)
Enterprise Value
5.70BCNY850.06M · vs all stocks (USD)
Trailing P/E
181.50xvs Medical Instruments & Supplies peers
Forward P/E
39.46xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
2.98xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
1.48xvs Medical Instruments & Supplies peers
Enterprise to Revenue
2.18xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
18.09xvs Medical Instruments & Supplies peers
Gross Margin
30.60%vs Medical Instruments & Supplies peers
Profit Margin
1.55%vs Medical Instruments & Supplies peers
Operating Margin
20.07%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
0.88%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
0.69%vs Medical Instruments & Supplies peers
Revenue (TTM)
2.61BCNY390.07M · vs all stocks (USD)
Revenue per Share (TTM)
6.06CNYUpdated Sep 21, 2026Quarterly Revenue Growth
44.10%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
434.66MCNY64.86M · vs all stocks (USD)
EBITDA (TTM)
213.49MCNY31.86M · vs all stocks (USD)
Net Income (TTM)
40.52MCNY6.05M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
39.31%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
247.01MCNY36.86M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-113.97MCNY-17.01M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.3500CNYUpdated Sep 21, 2026Trailing Annual Dividend Yield
1.89%vs all stocks
5-Year Average Dividend Yield
5.96%vs all stocks
Payout Ratio
357.87%vs Medical Instruments & Supplies peers
Minority Interest (Equity)
160.99MCNYFY2025 · Dec 31, 2025Revenue
2.37BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
2.11BCNYFY2025 · Dec 31, 2025Gross Profit
264.58MCNYFY2025 · Dec 31, 2025Operating Income
-53.29MCNY-7.95M · vs all stocks (USD)
Pre-tax Income
-124.11MCNYFY2025 · Dec 31, 2025Income Tax Expense
-7.63MCNYFY2025 · Dec 31, 2025Net Income
-116.48MCNYFY2025 · Dec 31, 2025EBIT
-93.08MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
213.49MCNYFY2025 · Dec 31, 2025Research & Development
51.08MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
81.80MCNYFY2025 · Dec 31, 2025Other Operating Expenses
25.48MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
45.41MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
31.03MCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.2600CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.2600CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
432.24MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
432.24MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-116.48MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
4.09MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-109.25MCNYFY2025 · Dec 31, 2025Free Cash Flow
-299.24MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
1.19BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-116.48MCNYFY2025 · Dec 31, 2025Other Non-cash Items
53.94MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
42.43MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-89.14MCNYFY2025 · Dec 31, 2025Capital Expenditures
-189.98MCNYFY2025 · Dec 31, 2025Net Acquisitions
0.00CNYFY2025 · Dec 31, 2025Purchase of Investments
-7.00BCNYFY2025 · Dec 31, 2025Sale of Investments
7.56BCNYFY2025 · Dec 31, 2025Other Investing Activity
8.88MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
377.00MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
1.15BCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-768.93MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-126.51MCNYFY2025 · Dec 31, 2025Other Financing Charges
2.74MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
253.48MCNYFY2025 · Dec 31, 2025Shares Outstanding
428.86MSharesUpdated Sep 21, 2026Float Shares
117.02MSharesUpdated Sep 21, 2026% Held by Insiders
72.30%vs all stocks
% Held by Institutions
1.29%vs all stocks
Total Cash (MRQ)
3.80BCNY567.40M · vs all stocks (USD)
Total Cash per Share (MRQ)
8.90CNYUpdated Sep 21, 2026Total Debt (MRQ)
1.58BCNY235.93M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.2918xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
2.53xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
12.30CNYUpdated Sep 21, 2026Total Assets
7.44BCNY1.11B · vs all stocks (USD)
Total Current Assets
4.73BCNYFY2025 · Dec 31, 2025Total Liabilities
2.02BCNYFY2025 · Dec 31, 2025Total Non-current Assets
2.71BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
253.44MCNYFY2025 · Dec 31, 2025Total Current Liabilities
1.76BCNYFY2025 · Dec 31, 2025Cash
1.00BCNYFY2025 · Dec 31, 2025Cash Equivalents
204.57MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
1.21BCNYFY2025 · Dec 31, 2025Other Short-term Investments
1.88BCNYFY2025 · Dec 31, 2025Accounts Receivable
401.59MCNYFY2025 · Dec 31, 2025Inventory
623.59MCNYFY2025 · Dec 31, 2025Accounts Payable
418.31MCNYFY2025 · Dec 31, 2025Short-term Debt
1.12BCNYFY2025 · Dec 31, 2025Other Current Liabilities
3.52MCNYFY2025 · Dec 31, 2025Long-term Debt
227.80MCNYFY2025 · Dec 31, 2025Common Stock (Book)
428.86MCNYFY2025 · Dec 31, 2025Retained Earnings
3.08BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
5.42BCNY809.03M · vs all stocks (USD)
Treasury Stock
18.99MCNYFY2025 · Dec 31, 202552-Week Low
9.21CNYUpdated Sep 21, 202652-Week High
18.80CNYUpdated Sep 21, 202652-Week Change
36.40%vs all stocks
Beta
0.3860xvs all stocks
50-Day MA
14.20CNYUpdated Sep 21, 2026200-Day MA
13.37CNYUpdated Sep 21, 2026Avg 10-Day Volume
11.68MSharesUpdated Sep 21, 2026Avg 30-Day Volume
16.91MSharesUpdated Sep 21, 2026Diluted EPS (TTM)
0.1000CNYUpdated Sep 21, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
Dividend several times the last twelve months' earningsSignificant
Payout Ratio: 3.58Dividend per Share: 0.35Earnings per Share: 0.10
Financial Health
Altman Z-Score 3.65: safe zoneNotable
Altman Z-Score: 3.65
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Jiangsu Allfavor Intelligent Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Lindsay Corporation
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Naruda Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
G-III Apparel Group, Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowInterface
Zhejiang Tony Electronic Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Seah Besteel Holdings Corporation
Tier 1ProductionThroughput-Bound ConversionFlow
Zhejiang Wanliyang Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Huafon Microfibre Shanghai Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Chengdu Galaxy Magnets Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowSenseMaking
Hainan Drinda New Energy Technology Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow